Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 12 studies | 29% ± 10% | |
glutamatergic neuron | 7 studies | 38% ± 22% | |
adventitial cell | 5 studies | 32% ± 11% | |
mesothelial cell | 4 studies | 22% ± 6% | |
luminal cell of prostate epithelium | 4 studies | 39% ± 11% | |
GABAergic neuron | 3 studies | 52% ± 5% | |
astrocyte | 3 studies | 25% ± 9% | |
interneuron | 3 studies | 42% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 34% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 16319.05 | 245 / 245 | 100% | 308.44 | 502 / 502 |
lung | 99% | 4904.26 | 570 / 578 | 88% | 14.99 | 1017 / 1155 |
esophagus | 95% | 2759.48 | 1378 / 1445 | 91% | 23.13 | 167 / 183 |
intestine | 100% | 2983.82 | 964 / 966 | 86% | 12.73 | 452 / 527 |
pancreas | 90% | 980.59 | 294 / 328 | 95% | 17.73 | 169 / 178 |
stomach | 94% | 2101.10 | 337 / 359 | 89% | 16.86 | 254 / 286 |
ovary | 100% | 3827.85 | 180 / 180 | 80% | 9.48 | 342 / 430 |
breast | 99% | 3445.24 | 456 / 459 | 75% | 15.87 | 834 / 1118 |
bladder | 100% | 3578.19 | 21 / 21 | 68% | 8.85 | 343 / 504 |
uterus | 98% | 2422.62 | 166 / 170 | 49% | 4.70 | 224 / 459 |
brain | 85% | 1735.82 | 2258 / 2642 | 56% | 5.01 | 392 / 705 |
kidney | 74% | 746.54 | 66 / 89 | 66% | 6.76 | 592 / 901 |
thymus | 99% | 1998.08 | 646 / 653 | 33% | 4.04 | 198 / 605 |
adrenal gland | 43% | 339.21 | 112 / 258 | 60% | 9.08 | 139 / 230 |
blood vessel | 100% | 2391.63 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 3307.66 | 1188 / 1204 | 0% | 0 | 0 / 0 |
skin | 85% | 2094.43 | 1543 / 1809 | 11% | 0.92 | 52 / 472 |
heart | 78% | 1493.50 | 673 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 4.73 | 29 / 45 |
liver | 31% | 276.97 | 69 / 226 | 31% | 3.16 | 124 / 406 |
spleen | 58% | 451.22 | 139 / 241 | 0% | 0 | 0 / 0 |
muscle | 10% | 117.24 | 84 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.37 | 2 / 29 |
peripheral blood | 5% | 51.31 | 45 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045055 | Biological process | regulated exocytosis |
GO_0015677 | Biological process | copper ion import |
GO_0009725 | Biological process | response to hormone |
GO_0098705 | Biological process | copper ion import across plasma membrane |
GO_0006897 | Biological process | endocytosis |
GO_0098711 | Biological process | iron ion import across plasma membrane |
GO_0006893 | Biological process | Golgi to plasma membrane transport |
GO_0010008 | Cellular component | endosome membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005768 | Cellular component | endosome |
GO_0005829 | Cellular component | cytosol |
GO_0030140 | Cellular component | trans-Golgi network transport vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0008823 | Molecular function | cupric reductase (NADH) activity |
GO_0052851 | Molecular function | ferric-chelate reductase (NADPH) activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | STEAP2 |
Protein name | Metalloreductase STEAP2 (EC 1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1) STEAP2 metalloreductase Six transmembrane epithelial antigen of the prostate 2, isoform CRA_a (Six transmembrane prostate protein v1) |
Synonyms | STAMP1 UNQ6507/PRO23203 PCANAP1 hCG_17233 |
Description | FUNCTION: Integral membrane protein that functions as a NADPH-dependent ferric-chelate reductase, using NADPH from one side of the membrane to reduce a Fe(3+) chelate that is bound on the other side of the membrane (By similarity). Mediates sequential transmembrane electron transfer from NADPH to FAD and onto heme, and finally to the Fe(3+) chelate (By similarity). Can also reduce Cu(2+) to Cu(1+) (By similarity). . |
Accessions | B5MC02 ENST00000394622.6 [Q8NFT2-1] Q8NFT2 C9JHX5 ENST00000394626.5 [Q8NFT2-2] ENST00000394621.7 [Q8NFT2-1] ENST00000428074.5 ENST00000394632.5 [Q8NFT2-3] ENST00000394629.2 [Q8NFT2-2] ENST00000287908.7 [Q8NFT2-1] ENST00000402625.6 C9JLP2 ENST00000426158.1 Q6YPB2 |